Skip to main content
Equibles
WAY logo

WAY · Waystar Holding Corp. · Metrics

Track WAY — free

Use WAY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research WAY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$28.98 +0.14 (+0.49%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.55B
Shares
191.75M
Volume · Oct 22 1.95M Avg daily vol (3M) 2.44M

WAY metrics

102 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$28.98
Market cap
$5.55B

Price action

20 metrics
Price change (1W)
+2.6%
Price change (30D)
+13.1%
Price change (3M)
+34.3%
Price change (6M)
+16.6%
Price change (YTD)
-11.5%
Price change (1Y)
-23.1%
Trailing year
Price change (5Y)
—
52-week high
$39.62
52-week low
$17.31
Change from 52-week high
-26.9%
Change from 52-week low
+67.4%
Annualized volatility
53.9%
Annualized volatility (3M)
53.5%
Beta
0.5
RSI (14D)
66.8
Price vs SMA 50
+12.7%
Price vs SMA 200
+20.7%
Avg volume (3M)
2.44M
Relative volume
0.8
Average dollar volume
$61.02M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
191.75M

Valuation

12 metrics
P / E (TTM)
41.4
Trailing earnings · reciprocal yield 2.4%
PEG ratio
2.5
EV / revenue
5.8×
reciprocal yield 17.2%
EV / EBITDA
16.2×
reciprocal yield 6.2%
EV / EBIT
25.4×
reciprocal yield 3.9%
P / sales
4.6×
reciprocal yield 21.7%
P / book
1.4
reciprocal yield 71.9%
FCF yield
4.4%
TTM · current market cap
Buyback yield
0.2%
P / FCF
22.5
reciprocal yield 4.4%
P / operating cash flow
18.9
reciprocal yield 5.3%
Earnings yield
2.4%

Historical valuation

8 metrics
P / E historical average (3Y)
83.3×
reciprocal yield 1.2%
P / E historical average (5Y)
83.3×
reciprocal yield 1.2%
EV / revenue historical average (3Y)
6.5×
reciprocal yield 15.5%
EV / revenue historical average (5Y)
6.5×
reciprocal yield 15.5%
EV / EBIT historical average (3Y)
31.2×
reciprocal yield 3.2%
EV / EBIT historical average (5Y)
31.2×
reciprocal yield 3.2%
EV / EBITDA historical average (3Y)
18.1×
reciprocal yield 5.5%
EV / EBITDA historical average (5Y)
18.1×
reciprocal yield 5.5%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.2%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-02
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
—
Operating margin
22.9%
Trailing 12 months
Net margin
11.2%
Gross profit (TTM)
—
Operating profit (TTM)
$275.76M
Net income (TTM)
$134.79M
Trailing 12 months
Diluted EPS (TTM)
$0.70
FCF margin
20.4%
Effective tax rate
30.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$6.29
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$1.44
EBITDA per diluted share (TTM)
$2.25
Net income per diluted share (TTM)
$0.70
Operating cash flow per diluted share (TTM)
$1.53
Free cash flow per diluted share (TTM)
$1.29
Capital expenditures per diluted share (TTM)
$0.24
R&D per diluted share (TTM)
$0.35
Stock compensation per diluted share (TTM)
$0.26
Book value per share
$20.25

Growth

11 metrics
Revenue growth YoY
+18.1%
Year over year
Net income growth YoY
+27.0%
Revenue (TTM)
$1.21B
Trailing 12 months
EPS growth YoY
+16.7%
Shares change YoY
+7.1%
Year over year · more shares
Revenue CAGR (3Y)
+16.0%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+49.2%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
3.4%
Return on assets
2.3%
Debt / equity
0.4
Current ratio
1.8
EBITDA (TTM)
$432.42M
Free cash flow (TTM)
$246.26M
Quick ratio
1.8
Interest coverage
—
Net debt / EBITDA
3.4
Return on invested capital
3.5%
Trailing 12 months
Net cash
−$1.45B
Latest balance sheet
Cash & equivalents
$12.64M
Total assets
$5.87B
Total debt
$1.47B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$292.99M
Capital expenditures (TTM)
$46.73M
R&D (TTM)
$67.01M
SG&A (TTM)
—
Stock compensation (TTM)
$49.04M
R&D / revenue
5.6%
Stock compensation / revenue
4.1%

Ownership (13F)

9 metrics
13F filers
303
13F filer change QoQ
-6
Institutional ownership
111.0%
Conviction holders (share of 13F filers)
3.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+3.7%
Holder tenure
5.8
Price vs estimated holder cost
-32.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
16.8%

Short interest

3 metrics
Short interest
8.3%
Latest settlement · 8.2 days to cover
Days to cover
8.2d
Short-squeeze score
82 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$6.37M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1990354 CUSIP 946784105 13F (30d) 45 filings 43 filers Visit website Investor relations